Star51 Capital
Overview
Star51 Capital is a venture capital firm that invests in early and growth-stage companies at the convergence of Medtech and AI, with a focus on interventional therapies, diagnostics, monitoring, and healthcare digitalization.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| UltraSight | Sep 2026 | Series B Extension | Co-investor |
Key People
Adam Rosenwach
Managing Partner
Tal Wenderow
Managing Partner
Jessica Richter
Domain Expert Venture Partner
Raymond W. Cohen
Partner
Anna Hildebrand
Inaugural Principal
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Star51 Capital based?
Star51 Capital is headquartered in New York City, New York, United States.
When was Star51 Capital founded?
Star51 Capital was founded in 2026.
How many portfolio companies does Star51 Capital have?
Star51 Capital has 1 portfolio company in Caplight's dataset.
What are some companies in Star51 Capital's portfolio?
Recent investments visible on Caplight include UltraSight.
What was Star51 Capital's most recent investment?
Star51 Capital's most recent investment on Caplight was in UltraSight in 2026.
What sectors does Star51 Capital focus on?
Star51 Capital focuses on Healthcare & Life Sciences, Enterprise Software.
What company stages does Star51 Capital focus on?
Star51 Capital typically invests at the Mid stage.